Monday, September 8, 2008 - 9:30AM EST

Review Articles

1. Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review.

Author
Eisen A; Trudeau M; Shelley W; Messersmith H; Pritchard KI;
Institution
Odette Cancer Centre, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5. andrea.eisen@sunnybrook.ca
Journal
Cancer Treat Rev. 2008 Apr;34(2):157-74. Epub 2007 Dec 31.
Abstract URL
Click here to view abstract

2. Advances in the treatment of breast cancer.

Author
Moulder S; Hortobagyi GN;
Institution
Department of Breast Medical Oncology and Phase I Program, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. smoulder@mdanderson.org
Journal
Clin Pharmacol Ther. 2008 Jan;83(1):26-36. Epub 2007 Dec 19.
Abstract URL
Click here to view abstract

3. Hereditary breast cancer: part I. Diagnosing hereditary breast cancer syndromes.

Author
Lynch HT; Silva E; Snyder C; Lynch JF;
Institution
Department of Preventive Medicine and Public Health, Creighton University School of Medicine, Omaha, Nebraska 68178, USA. htlynch@creighton.edu
Journal
Breast J. 2008 Jan-Feb;14(1):3-13. Epub 2007 Dec 11.
Abstract URL
Click here to view abstract

4. Aromatase inhibitors in early hormone receptor-positive breast cancer : what is the optimal initiation time for the maximum benefit?

Author
Needleman SJ; Tobias JS;
Institution
Department of Oncology, University College Hospital, London, UK.
Journal
Drugs. 2008;68(1):1-15.
Abstract URL
Click here to view abstract

5. Subsequent pregnancy after breast cancer.

Author
Peccatori F; Cinieri S; Orlando L; Bellettini G;
Institution
Department of Medicine, Istituto Europeo di Oncologia, Milan, Italy.
Journal
Recent Results Cancer Res. 2008;178:57-67.

6. Breast cancer during pregnancy: medical therapy and prognosis.

Author
Aebi S; Loibl S;
Institution
University Hospital Bern, Inselspital, Breast and Gynecologic Cancer Center, Switzerland.
Journal
Recent Results Cancer Res. 2008;178:45-55.

7. Oral contraceptive use and risk of breast cancer.

Author
Casey PM; Cerhan JR; Pruthi S;
Institution
Department of Obstetrics and Gynecology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. casey.petra@mayo.edu
Journal
Mayo Clin Proc. 2008 Jan;83(1):86-90; quiz 90-1.
Abstract URL
Click here to view abstract

8. Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials.

Author
Early Breast Cancer Trialists' Collaborative Group; Clarke M; Coates AS; Darby SC; Davies C; Gelber RD; Godwin J; Goldhirsch A; Gray R; Peto R; Pritchard KI; Wood WC;
Institution
Journal
Lancet. 2008 Jan 5;371(9606):29-40.
Abstract URL
Click here to view abstract

9. Recent advances in the hormonal treatment of breast cancer.

Author
Boughey JC; Buzdar AU; Hunt KK;
Institution
Mayo Clinic, Rochester, Minnesota, USA.
Journal
Curr Probl Surg. 2008 Jan;45(1):13-55.

10. Hormono-biological therapy in metastatic breast cancer: preclinical evidence, clinical studies and future directions.

Author
Tonini G; Schiavon G; Fratto ME; Vincenzi B; Santini D;
Institution
University Campus Bio-Medico, Medical Oncology, Via Emilio Longoni, 83 00155 Rome, Italy. g.tonini@unicampus.it
Journal
Expert Opin Biol Ther. 2008 Feb;8(2):221-34.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6